Glaukos Corp (GKOS)
120.89
+1.44%
Glaukos Corp (GKOS) is currently trading at $120.89. This represents a gain of 1.44% from the previous session. With a market capitalization of $7.02B, GKOS is a key component of the Health Care sector. Investors looking to trade GKOS should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade GKOS commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Glaukos Corp (GKOS) shows a bullish trend. Analysts are watching the 121.72 level closely.
Fundamentals
Mkt Cap7.02B
P/E Ratio0.0000
Volume0
60-Day Technical Chart
Advanced Charting
Need more indicators for GKOS? Use the world's #1 platform.
Open GKOS on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $121
| Metric |
GKOS +1.44% |
ATZ +2.50% |
A +0.26% |
ABNB +5.06% |
|---|---|---|---|---|
| Price | $120.89 | $129.26 | $124.72 | $132.02 |
| Mkt Cap | $7.02B | $15.14B | $35.28B | $80.36B |
| - | View → | View → | View → |
Latest Headlines
Strong Results with 38.1% Revenue Growth Lifted Glaukos (GKOS) in Q4
Bitget • Feb 23, 2026
$GKOS stock is up 11% today. Here's what we see in our data.
Quiver Quantitative • Feb 18, 2026
GKOS Stock Surges Following Q3 Earnings & Revenue Beat, Guidance Raised
Zacks Investment Research • Oct 30, 2025
FDA approves repeat use of Glaukos glaucoma eye implant iDose TR
Stock Titan • Jan 28, 2026
Will Glaukos (GKOS) Report Negative Earnings Next Week? What You Should Know
Yahoo Finance • Oct 22, 2025
● Gemini Agentic AI Analyst Insight for GKOS
Market Education
- Government Shutdowns: What They Mean for Wall Street Sep 26, 2025
- Cannabis Stocks Apr 8, 2024
- I am a newbie Trader, how do I start trading Jul 15, 2023
External Research